Macromoltek

Winter 2018Active

Computational antibody design

Save

Macromoltek

Winter 2018Active

Computational antibody design

Save

Company details

Macromoltek: Revolutionizing antibody design.

Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Location

Austin, TX, USA

Founded

Unknown

Request the Macromoltek report.

Macromoltek has no report yet. Sign in with your email to request one.